$0.27
-0.01 (-1.96%)
Open$0.28
Previous Close$0.28
Day High$0.29
Day Low$0.27
52W High$27.15
52W Low$16.44
Volume—
Avg Volume266.1K
Market Cap55.34M
P/E Ratio30.53
EPS$0.61
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+7,532.9% upside
Current
$0.27
$0.27
Target
$20.96
$20.96
$15.05
$20.96 avg
$24.54
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 26.00M | 22.93M | 28.87M |
| Net Income | -3,802,417 | -3,978,629 | -3,915,216 |
| Profit Margin | -14.6% | -17.4% | -13.6% |
| EBITDA | -5,256,206 | -4,739,765 | -5,087,055 |
| Free Cash Flow | -3,224,852 | -2,115,724 | -2,331,954 |
| Rev Growth | +20.6% | +0.2% | +12.7% |
| Debt/Equity | 0.27 | 0.28 | 0.30 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |